Wall Street speculates on J&J's next heart device move

12/8/2005 | MSNBC

Boston Scientific's bid over Johnson & Johnson this week for heart device maker Guidant may send J&J looking elsewhere to enter the pacemaker market. Some Wall Street analysts speculate there's only a 50-50 chance that J&J will raise its bid for Guidant, and that the company may instead turn its eyes to St. Jude Medical, of St. Paul, Minn.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Fort Worth, TX
Senior Scientist - Cell Engineering Group
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC